S. 641

119th Congress

In Committee

Safe and Affordable Drugs from Canada Act of 2025

Sponsored byDemocrat:Sen. Klobuchar, Amy [D-MN]MN· Introduced 19 February 2025

7

Cosponsors

2

Actions

0

Amendments

0

Committees

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

19 February 2025·1 year ago

Summary

Introduced in Senate · Updated 14 May 2025

Safe and Affordable Drugs from Canada Act of 2025

This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances.

Such a drug must (1) be purchased from an approved Canadian pharmacy and dispensed by a pharmacist licensed in Canada; (2) be purchased by an individual for personal use only and in quantities not to exceed a 90-day supply; (3) be filled using a valid prescription from a physician licensed in a U.S. state; and (4) have the same active ingredients, route of administration, dosage form, and strength as an FDA-approved drug. Certain types of drugs may not be imported under this program, such as controlled substances, biological products, or intravenously injected drugs.

An approved pharmacy under this program must be located and licensed in Canada and meet additional requirements, such as participation in ongoing and comprehensive quality assurance programs.

The FDA must publish a list of approved Canadian pharmacies on its website.

Timeline

2 actions

  1. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    19 February 2025 · IntroReferral

  2. Introduced in Senate

    19 February 2025 · IntroReferral

Sponsorship

7 cosponsors

Sponsor

Democrat:Sen. Klobuchar, Amy [D-MN]MN

Cosponsors

  • Democrat571%
  • Republican114%
  • Independent114%

Classification

Policy area

Health

Legislative subjects

Administrative law and regulatory proceduresCanadaDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationGovernment information and archivesPrescription drugsTrade restrictions
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.